Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scheid

Showing results (1161-1170 of 1,291) with videos related to

Pageof 130
Sort By:
BMC Cancer|May 30, 2019
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myelomaHans Salwender, Uta Bertsch, Katja Weisel, et al.
Blood Advances|May 29, 2024
PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMTJuan Montoro, Maud Ngoya, Alexander Kulagin, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|February 2, 2011
Anthropocene streams and base-level controls from historic dams in the unglaciated mid-Atlantic region, USADorothy Merritts, Robert Walter, Michael Rahnis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2018
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel AgentsFiroozeh Sahebi, Simona Iacobelli, Giulia Sbianchi, et al.
Journal of Pineal Research|May 28, 2011
Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disordersPauline Chaste, Nathalie Clement, Hany Goubran Botros, et al.
Journal of the American Medical Informatics Association : JAMIA|February 22, 2022
Extracting seizure frequency from epilepsy clinic notes: a machine reading approach to natural language processingKevin Xie, Ryan S Gallagher, Erin C Conrad, et al.
Blood|June 12, 2025
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRSTMaximilian Merz, Nico Gagelmann, Samih Smaili, et al.
Cardio-Oncology (London, England)|July 4, 2025
Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trialLisa B Leypoldt, Linlin Guo, Britta Besemer, et al.
Cell Reports. Medicine|February 10, 2024
An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCLLars Fabian Prinz, Tobias Riet, Daniel Felix Neureuther, et al.
Blood Advances|March 25, 2026
Real-world experience with Tabelecleucel within and beyond the approval labelKiavasch Mohammad Nejad Farid, Florian Kocher, Tobias Arnold, et al.
Pageof 130

Showing results (1161-1170 of 1,291) with videos related to

Sort By:
Pageof 130
BMC Cancer|May 30, 2019
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myelomaHans Salwender, Uta Bertsch, Katja Weisel, et al.
Blood Advances|May 29, 2024
PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMTJuan Montoro, Maud Ngoya, Alexander Kulagin, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|February 2, 2011
Anthropocene streams and base-level controls from historic dams in the unglaciated mid-Atlantic region, USADorothy Merritts, Robert Walter, Michael Rahnis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2018
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel AgentsFiroozeh Sahebi, Simona Iacobelli, Giulia Sbianchi, et al.
Journal of Pineal Research|May 28, 2011
Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disordersPauline Chaste, Nathalie Clement, Hany Goubran Botros, et al.
Journal of the American Medical Informatics Association : JAMIA|February 22, 2022
Extracting seizure frequency from epilepsy clinic notes: a machine reading approach to natural language processingKevin Xie, Ryan S Gallagher, Erin C Conrad, et al.
Blood|June 12, 2025
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRSTMaximilian Merz, Nico Gagelmann, Samih Smaili, et al.
Cardio-Oncology (London, England)|July 4, 2025
Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trialLisa B Leypoldt, Linlin Guo, Britta Besemer, et al.
Cell Reports. Medicine|February 10, 2024
An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCLLars Fabian Prinz, Tobias Riet, Daniel Felix Neureuther, et al.
Blood Advances|March 25, 2026
Real-world experience with Tabelecleucel within and beyond the approval labelKiavasch Mohammad Nejad Farid, Florian Kocher, Tobias Arnold, et al.
Pageof 130